联合健康

UnitedHealth Group's 15min chart sees MACD Death Cross, Bollinger Bands Narrowing.

UnitedHealth Group: Mizuho Downgrades to Outperform, PT to $350 from $430.

UnitedHealth Group

UnitedHealth's Value-Based Care Strategy Through Optum: A Key Growth Driver

India to proceed with T20WC match against Pakistan despite boycott announcement.

Elevance Health

ASML Holding

United Parcel

Manning & Napier Group's Q4 2025 Portfolio Adjustments: Significant Reductions and Increases

Catalyst<ul> <li>Most analysts rate UNH Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state and the direction is not clear enough.</li> <li>Recent technical signals are scarce and the market is relatively calm.</li></ul>

Key Factors

UnitedHealth Group’s stock plunges 2.91% amid regulatory scrutiny and PBM rule changes, ranking 33rd in trading activity. CMS proposes a 0.09% Medicare Advantage rate increase for 2027, sparking sector-wide concerns for UnitedHealth, which derives 38% of revenue from this segment. UnitedHealth’s Q4 revenue misses estimates at $113.2 billion, leading to a 21.5% stock drop despite beating EPS expectations.

Recent Updates

UNH News